Interestingly, this combination therapy significantly ameliorated both clinical and histopathological signs of arthritis, thus indicating a potential for a broader range of kinase inhibitors to synergize with anti-TNF agents to efficiently treat arthritis pathology (Fig. 5c, d). The gene discussed is TNF; the disease is arthritic joint disease.